Listed by the USPTO as GRIZER, CASSANDRA SENN
Tech Center 1600 • Art Units: 1600 1671 1672 1675
This examiner grants 70% of resolved cases
Cassandra Senn Grizer is a USPTO patent examiner in tech center 1600 and art unit 1600. The available record includes 10 resolved cases, a 70.0% allowance rate, and a median of 1143 days to allowance. The interview lift is 48.0%, indicating a substantial measured association between interviews and allowance outcomes. With only 10 resolved cases, the profile is limited in scope, so practitioners should use the figures as an initial signal and review comparable applications directly.
The listed companies are Astrazeneca AB, CJ CheilJedang Corporation, and Massachusetts Institute of Technology. The leading firms are ARENTFOX SCHIFF LLP, Riverside Law LLP, and BakerHostetler. These organizations place the available record in pharmaceutical, biotechnology, and institutional research contexts.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18277879 | NOVEL BACTERIOPHAGE HAVING CLOSTRIDIUM PERFRINGENS-SPECIFIC BACTERICIDAL EFFECT AND ANTIBACTERIAL COMPOSITION COMPRISING SAME | Non-Final OA | CJ CheilJedang Corporation |
| 18686564 | MULTIVALENT VIRAL PARTICLES | Non-Final OA | CORNELL UNIVERSITY |
| 18273053 | MICROTUBULE DESTABILIZER ADDITIVES TO INCREASE RECOMBINANT VIRAL VECTOR TITERS | Non-Final OA | Biogen MA Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy70.0% of resolved applications examined by Cassandra Senn Grizer were allowed (10 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +48.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Cassandra Senn Grizer took 1,143 days on average from filing to allowance.
Cassandra Senn Grizer examines applications in Art Unit 1600 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
